Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.

Autor: Bezerra Salomão, Karina, Cruzeiro, Gustavo Alencastro Veiga, Bonfim-Silva, Ricardo, Geron, Lenisa, Ramalho, Fernando, Pinto Saggioro, Fabiano, Serafini, Luciano Neder, Antunes Moreno, Daniel, de Paula Queiroz, Rosane Gomes, dos Santos Aguiar, Simone, Cardinalli, Izilda, Yunes, José Andres, Brandalise, Silvia Regina, Brassesco, Maria Sol, Scrideli, Carlos Alberto, Gonzaga Tone, Luiz

Publikováno v: Journal of Neuro-Oncology; Aug2018, Vol. 139 Issue 1, p33-42, 10p

Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells

Autor: Alejandra Pezuk, Julia, Sol Brassesco, Maria, Maria Manzini Ramos, Priscila, Alberto Scrideli, Carlos, Gonzaga Tone, Luiz

Publikováno v: Anti-Cancer Agents in Medicinal Chemistry; August 2017, Vol. 17 Issue: 9 p1278-1291, 14p

Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia.

Autor: Canalle, Renata, Silveira, Vanessa S., Alberto Scrideli, Carlos, Queiroz, Rosane G. P., Fernando Lopes, Luiz, Gonzaga Tone, Luiz

Publikováno v: Leukemia & Lymphoma; Jun2011, Vol. 52 Issue 6, p1118-1126, 9p, 3 Charts

Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.

Autor: de Almeida Magalhães T; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Alencastro Veiga Cruzeiro G; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Ribeiro de Sousa G; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Englinger B; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Fernando Peinado Nagano L; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Ancliffe M; Brain Tumour Research Program, Telethon Kids Institute and the University of Western Australia, Nedlands, Western Australia, Australia., Rodrigues da Silva K; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Brain Tumour Research Program, Telethon Kids Institute and the University of Western Australia, Nedlands, Western Australia, Australia., Jiang L; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Gojo J; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria., Cherry Liu Y; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Carline B; Brain Tumour Research Program, Telethon Kids Institute and the University of Western Australia, Nedlands, Western Australia, Australia., Kuchibhotla M; Brain Tumour Research Program, Telethon Kids Institute and the University of Western Australia, Nedlands, Western Australia, Australia., Pinto Saggioro F; Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Kazue Nagahashi Marie S; Cellular and Molecular Biology Laboratory, Department of Neurology, Faculdade de Medicina (FMUSP), University of São Paulo, São Paulo, Brazil., Mieko Oba-Shinjo S; Cellular and Molecular Biology Laboratory, Department of Neurology, Faculdade de Medicina (FMUSP), University of São Paulo, São Paulo, Brazil., Andres Yunes J; Molecular Biology Laboratory, Boldrini Children's Center, Campinas, São Paulo, Brazil., Gomes de Paula Queiroz R; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Alberto Scrideli C; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Endersby R; Brain Tumour Research Program, Telethon Kids Institute and the University of Western Australia, Nedlands, Western Australia, Australia., Filbin MG; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Silva Borges K; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA., Salic A; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Gonzaga Tone L; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Valera ET; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Publikováno v: Neuro-oncology [Neuro Oncol] 2023 Jan 05; Vol. 25 (1), pp. 185-198.